跳至主要内容
临床试验/NCT01098812
NCT01098812已完成3 期

Clinical Evaluation of the TECNIS® Toric 1-Piece Intraocular Lens

Abbott Medical Optics0 个研究点目标入组 269 人开始时间: 2010年3月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
269
主要终点
Mean Percent Reduction in Cylinder

研究概览

简要总结

The aims of this study are to:

  • Demonstrate a reduction in postoperative cylinder compared to results from the control lens
  • Demonstrate better uncorrected distance visual acuity compared to the control lens

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Minimum 18 years of age
  • Cataract for which phacoemulsification extraction and posterior chamber IOL implantation has been planned for both eyes
  • Preoperative best corrected distance visual acuity (BCDVA)of 20/40 or worse (Snellen), with or without glare, for each eye
  • BCDVA projected to be better than 20/30 following cataract removal and IOL implantation for each eye
  • Preoperative keratometric cylinder of 0.75 diopters to 3.62 diopters for each eye (with exception of second eyes with 0.0-0.75 diopters planned to receive non-toric IOL)
  • Clear intraocular media other than cataract in both eyes
  • Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visits
  • Signed informed consent and HIPAA authorization

排除标准

  • Requiring IOLs outside spherical power range of +15.0 to +28.0 diopters
  • Dilated pupil size less than 5.5 mm or the presence of any pupil abnormalities (non-reactive, fixed pupils, or abnormally shaped pupils)in either eye
  • Previous corneal or intraocular surgery in either eye
  • Irregular corneal astigmatism in either eye
  • Corneal pathology/abnormality potentially affecting topography in either eye
  • Corneal abnormalities such as stromal, epithelial or endothelial dystrophies in either eye
  • Inability to achieve keratometric stability in either eye for contact lens wearers
  • Subjects with diagnosed degenerative visual disorders in either eye(eg., macular degeneration or other retinal disorders) that are predicted to cause future acuity losses to a level of 20/30 or worse
  • Subjects with conditions associated with increased risk of zonular rupture, including capsular or zonular abnormalities that may lead to IOL decentration, including pseudoexfoliation, trauma, or posterior capsule defects
  • An eccentric anterior capsulorhexis, zonular damage/rupture or capsular tear/rupture during the cataract extraction procedure
  • Use of systemic or ocular medications that may affect vision
  • Prior, current, or anticipated use during the course of the nine month study of tamsulosin or silodosin (e.g., Flomax, Flomaxtra, Rapaflo)likely to affect dilation or iris structure
  • Poorly-controlled diabetes
  • Acute, chronic, or uncontrolled systemic disease or illness that would, in the opinion of the investigator, increase the operative risk or confound the outcome(s) of the study (e.g., immunocompromised, connective tissue disease, etc.)
  • Uncontrolled ocular hypertension or glaucomatous changes in the retina or visual field in either eye
  • Known ocular disease or pathology that may affect visual acuity or that may require surgical intervention during the course of the study (macular degeneration, cystoid macular edema, diabetic retinopathy, etc.)
  • Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with the fluctuation of hormones that could lead to refractive changes
  • Concurrent participation or participation during 30 days prior to preoperative visit in any other clinical trial

结局指标

主要结局

Mean Percent Reduction in Cylinder

时间窗: 6 months after second eye implant compared to baseline

Reduction in cylinder postoperatively vs. preoperatively (baseline) as measured by keratometry and manifest refraction. Mean percent reduction in cylinder = (postoperative refractive cylinder minus preoperative keratometric cylinder)/(target refractive cylinder minus preoperative keratometric cylinder). Reduction in cylinder was assessed in the first eye (per participant) for contribution to the mean.

次要结局

  • Uncorrected Distance Visual Acuity (UCDVA)(6 months after second eye implant)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验